Abstract
Prostate cancer is the second most diagnosed cancer in men next to skin cancer in the developed world. Risk of disease varies most prominently with age, ethnicity, family history, and diet. Genetic polymorphism of some genes has been implicated in increasing the risk. The XPD (Xeroderma pigmentosum group D) gene codes for a DNA helicase involved in transcription and nucleotide excision repair. The aim of this study is to evaluate the effect of XPD 751 Lys/Gln polymorphism on risk of prostate cancer on north Indian patients. Blood sample from 150 prostate cancer patients, 150 from Prostate Hyper Plasia and equal number of samples from healthy control groups was collected from North India. The polymerase chain reaction and restrictive fragment length polymorphism techniques were implemented. Statistically non-significant increase risk of prostate cancer was observed with patients having Gln/Gln genotype (OR 1.62, 95% CI).
Similar content being viewed by others
References
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics. CA Cancer j clin 58(2):71–96
Grant WB (2004) A multicountry ecologic study of risk and risk reduction factors for prostate cancer mortality. Eur Urol 45:271–279
UK Prostate cancer statistics (2008) Cancer Research UK. http://info.cancerresearchuk.org/. Accessed 23/12/2009
Tannock I, de Wit R, Berry W (2004) Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 351:1502–1512
Yeole BB, Jussawala DJ (1998) An assessment of reliability and completeness of Bombay cancer registry in India. Indian J Cancer 25:177–190
Clinton SK (1998) Diet, nutrition, and prostate cancer. Annu Rev Nutr 18:413–440
Pienta KJ, Esper PS (1993) Risk factors for prostate cancer. Ann Intern Med 118:793–803
Poirier MC, Weston A (2000) DNA damage, DNA repair, and mutagenesis. In: Bertino JR (ed) Encyclopedia of cancer. Academic Press, Boston, pp 79–87
Ford D, Easton DF, Bishop DT, Narod SA, Goldger DE (1994) Risk of cancer in BRCA1 mutation carriers. Lancet 343:692–695
Weber CA, Salazar EP, Stewart SA (1990) ERCC2: cDNA cloning and molecular characterization of a human nucleotide excision repair gene with high homology to yeast RAD3. EMBO J 9:1437–1447
Itin PH, Sarasin A, Pittelkow MR (2001) Trichothiodystrophy: update on the sulfur-deficient brittle hair syndromes. J Am Acad Dermatol. 44:891–920
Rybicki BA, Conti DV, Moreira A, Cicek M, Casey G, Witte JS (2004) DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 13:23–29
Shen MR, Jones IM, Mohrenweiser H (1998) Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 58:604–608
Stern MC, Umbach DM, Lunn RM, Taylor JA (2002) DNA repair gene XRCC3 codon 241 polymorphism, its interaction with smoking and XRCC1 polymorphisms, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 11:939–943
Butkiewicz D, Rusin M, Enewold L, Shields PG, Chorazy M, Harris CC (2001) Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis 22:593–597
Rybicki BA, Nock NL, Savera AT, Tang D, Rundl A (2006) Polycyclic aromatic hydrocarbon-DNA adduct formation in prostate carcinogenesis. Cancer Lett 239:157–167
Agalliu I, Kwon EM, Salinas CA, Koopmeiners JS, Ostrander EA, Stanford JL (2010) Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes Control 21:289–300
Wood RD, Mitchell M, Sgouros J, Lindahl T, Human (2001) Human DNA repair genes. Science 291:1284–1289
Braithwaite E, Wu X, Wang Z (1998) Repair of DNA lesions induced by polycyclic aromatic hydrocarbons in human cell-free extracts: involvement of two excision repair mechanisms in vitro. Carcinogenesis 19:1239–1246
Christmann M, Tomicic MT, Roos WP, Kaina B (2003) Mechanisms of human DNA repair: an update. Toxicology 193:3–34
Bau DT, Wu HC, Chiu C, Lin CC, Hsu CM, Wang CL (2007) Association of XPD polymorphisms with prostate cancer in Taiwanese patients. Anticancer Res. 27:2893–2896
Gangwar R, Manchanda PK, Mittal RD (2009) Implications of XRCC1, XPD and APE1 gene polymorphism in North Indian population: a comparative approach in different ethnic groups worldwide. Genetica 136:163–169
Hu JJ, Hall MC, Grossman L, Hedayati M, McCullough DL, Lohman K (2004) Deficient nucleotide excision repair capacity enhances human prostate cancer risk. Cancer Res 64:1197–1201
U.S. Department of Health and Human Services: The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004
Hickey K, Do KA, Green A (2001) Smoking and prostate cancer. Epidemiol Rev 23:115–125
Rohrmann S, Genkinger JM, Burke A, Helzlsouer KJ, Comstock GW, Alberg AJ, Platz ES (2007) Smoking and risk of fatal prostate cancer in a prospective US study. Urology 69:721–725
Butler LM, Wang R, Wong AS, Koh WP, Yu MC (2009) Cigarette smoking and risk of prostate cancer among Singapore Chinese. Cancer Causes Control 20:1967–1974
Sesso HD, Paffenbarger RS, Lee IM (2001) Alcohol consumption and risk of prostate cancer; The Harvard Alumni health study. Int J Epidemol 30:749–755
Moller JO, Paine SL, McMichael AJ, Ewertz M, Schottenfeld D, Fraumeni JF (1996) Cancer epidemiology and prevention, 2nd edn. New York, Oxford, pp 290–318
Dennis LK, Hayes RB (2001) Alcohol and prostate cancer. Epidemiol Rev. 23:110–114
Platz EA, Leitzmann MF, Rim EB, Willett WC, Giovannucci E (2003) Alcohol intake, drinking patterns, and risk of prostate cancer in a large prospective cohort study. Am J Epidemiol 159:444–453
Albertsen K, Gronbaek M (2002) Does amount or type of alcohol influence the risk of prostate cancer? Prostate 52:297–304
Lund TI, Johnsen R, Vatten LJ (2000) Socio-economic and lifestyle factors associated with the risk of prostate cancer. Br J Cancer 8:1358–1363
Ellison LF (2000) Tea and other beverage consumption and prostate cancer risk: a Canadian retrospective cohort study. Eur J Cancer Prev 9:125–130
Schoonen WM, Salinas CA, Kiemeney LA, Stanford JL (2005) Alcohol consumption and risk of prostate cancer in middle-aged men. Int J Cancer 113:133–140
Acknowledgments
The authors of this article are grateful for the clinical staff at the Department of Urology in postgraduate education and medical research, Chandigarh, India, for the kind assistant provided during sample collections.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sobti, R.C., Berhane, N., Melese, S. et al. Impact of XPD gene polymorphism on risk of prostate cancer on north Indian population. Mol Cell Biochem 362, 263–268 (2012). https://doi.org/10.1007/s11010-011-1152-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-011-1152-3